| Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome studied in …STUDIED_INderived15 of 15show fewer |
|---|
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02126553Phase 2 · completed Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01834248Phase 1 · completed DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307579Phase 3 · completed Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132586Phase 1 · completed Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 15 trials mapped (1 active) | — | — | Alkylating Agent-Related Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |